• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.

作者信息

Naik H B, Alhusayen R, Frew J, Guilbault S, Ingram J R, Lowes M A, Marzano A V, Paul M, Villumsen B, Yannuzzi C A

机构信息

Department of Dermatology, University of California, San Francisco, CA, USA.

Sunnybrook Research Institute, Dermatology Division, Department of Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

Br J Dermatol. 2020 Oct;183(4):780-781. doi: 10.1111/bjd.19345. Epub 2020 Aug 2.

DOI:10.1111/bjd.19345
PMID:32597495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361290/
Abstract
摘要

相似文献

1
Global Hidradenitis Suppurativa COVID-19 Registry: a registry to inform data-driven management practices.全球化脓性汗腺炎新型冠状病毒肺炎登记处：一个为基于数据的管理实践提供信息的登记处。
Br J Dermatol. 2020 Oct;183(4):780-781. doi: 10.1111/bjd.19345. Epub 2020 Aug 2.
2
Remote management of hidradenitis suppurativa in a pandemic era of COVID-19.COVID-19大流行时代化脓性汗腺炎的远程管理
Int J Dermatol. 2020 Sep;59(9):e318-e320. doi: 10.1111/ijd.15022. Epub 2020 Jun 23.
3
Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.银屑病和特应性皮炎中新型冠状病毒肺炎病例的全球报告：大流行期间为医疗护理提供信息的一个契机。
Br J Dermatol. 2020 Aug;183(2):404-406. doi: 10.1111/bjd.19161. Epub 2020 Jun 10.
4
Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations.阿达木单抗在2019冠状病毒病大流行期间用于治疗化脓性汗腺炎：安全性考量
J Am Acad Dermatol. 2020 Jul;83(1):e31. doi: 10.1016/j.jaad.2020.04.030. Epub 2020 Apr 10.
5
Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.评估在2019冠状病毒病大流行期间使用阿达木单抗治疗化脓性汗腺炎的风险。
J Am Acad Dermatol. 2020 Dec;83(6):e433-e434. doi: 10.1016/j.jaad.2020.07.086. Epub 2020 Jul 28.
6
Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?慢性炎症性皮肤病与生物制剂：新冠疫情大流行之后的展望？
Int J Dermatol. 2020 Sep;59(9):1144-1145. doi: 10.1111/ijd.15059. Epub 2020 Jul 25.
7
The American Academy of Dermatology COVID-19 registry: Crowdsourcing dermatology in the age of COVID-19.美国皮肤科协会COVID-19登记处：COVID-19时代的皮肤科众包
J Am Acad Dermatol. 2020 Aug;83(2):509-510. doi: 10.1016/j.jaad.2020.04.045. Epub 2020 Apr 17.
8
COVID-19 and cancer: do we really know what we think we know?COVID-19 与癌症：我们真的了解我们自以为了解的吗？
Nat Rev Clin Oncol. 2020 Jul;17(7):386-388. doi: 10.1038/s41571-020-0394-y.
9
Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.评估在2019冠状病毒病大流行期间使用度普利尤单抗治疗特应性皮炎的风险。
J Am Acad Dermatol. 2020 Sep;83(3):e251-e252. doi: 10.1016/j.jaad.2020.06.015. Epub 2020 Jun 10.
10
Crucial Conversations With Patients in the Era of COVID-19.COVID-19时代与患者的关键对话
Circulation. 2020 Jul 21;142(3):191-193. doi: 10.1161/CIRCULATIONAHA.120.047374. Epub 2020 May 6.

引用本文的文献

1
Use of Clinical Public Databases in Hidradenitis Suppurativa Research.临床公共数据库在化脓性汗腺炎研究中的应用。
Interact J Med Res. 2025 Feb 18;14:e70282. doi: 10.2196/70282.
2
Guidance on COVID-19 Vaccination in Hidradenitis Suppurativa Patients: A Modified Delphi Consensus of Experts.化脓性汗腺炎患者新冠疫苗接种指南：专家修改后的德尔菲共识
Skin Appendage Disord. 2022 Jul;8(4):287-290. doi: 10.1159/000521268. Epub 2022 Jan 10.
3
Dermatology COVID-19 Registries: Updates and Future Directions.皮肤科 COVID-19 登记处：更新和未来方向。
Dermatol Clin. 2021 Oct;39(4):575-585. doi: 10.1016/j.det.2021.05.013. Epub 2021 May 31.
4
Clinical Dermatology and COVID-19 Pandemic: Narrative Review.临床皮肤病学与新冠疫情：叙述性综述
Indian J Dermatol. 2021 May-Jun;66(3):246-255. doi: 10.4103/ijd.ijd_463_21.
5
Coronavirus disease 2019 complications in patients with hidradenitis suppurativa: A multicenter analysis.化脓性汗腺炎患者的2019冠状病毒病并发症：一项多中心分析。
J Dermatol. 2021 Oct;48(10):1619-1621. doi: 10.1111/1346-8138.16073. Epub 2021 Aug 17.
6
Anti-COVID-19 measurements for hidradenitis suppurativa patients.防治化脓性汗腺炎患者感染 COVID-19 的措施。
Exp Dermatol. 2021 Jun;30 Suppl 1(Suppl 1):18-22. doi: 10.1111/exd.14339.
7
Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019.2019年冠状病毒病管理的数字健康监测策略
Mayo Clin Proc Innov Qual Outcomes. 2021 Feb;5(1):109-117. doi: 10.1016/j.mayocpiqo.2020.12.004. Epub 2020 Dec 14.
8
COVID-19 in patients with hidradenitis suppurativa.化脓性汗腺炎患者中的新型冠状病毒肺炎
Br J Dermatol. 2021 Jan;184(1):182-184. doi: 10.1111/bjd.19492. Epub 2020 Sep 24.
9
Association of COVID-19 with skin diseases and relevant biologics: a cross-sectional study using nationwide claim data in South Korea.COVID-19 与皮肤病及相关生物制剂的关联：使用韩国全国理赔数据的横断面研究。
Br J Dermatol. 2021 Feb;184(2):296-303. doi: 10.1111/bjd.19507. Epub 2020 Oct 13.

本文引用的文献

1
Malignancy and infection risk during adalimumab therapy in hidradenitis suppurativa.阿达木单抗治疗化脓性汗腺炎的恶性肿瘤和感染风险。
Clin Exp Dermatol. 2020 Oct;45(7):859-865. doi: 10.1111/ced.14264. Epub 2020 May 26.
2
Is ethnicity linked to incidence or outcomes of covid-19?种族与新冠病毒疾病2019的发病率或预后有关吗？
BMJ. 2020 Apr 20;369:m1548. doi: 10.1136/bmj.m1548.
3
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日，14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.
4
Covid-19: Black people and other minorities are hardest hit in US.新冠疫情：美国黑人及其他少数族裔受影响最为严重。
BMJ. 2020 Apr 14;369:m1483. doi: 10.1136/bmj.m1483.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa.比较化脓性汗腺炎患者的总体合并症负担。
JAMA Dermatol. 2019 Jul 1;155(7):797-802. doi: 10.1001/jamadermatol.2019.0164.
7
Prevalence Estimates for Hidradenitis Suppurativa among Children and Adolescents in the United States: A Gender- and Age-Adjusted Population Analysis.美国儿童和青少年化脓性汗腺炎的患病率估计：一项性别和年龄调整的人口分析。
J Invest Dermatol. 2018 Oct;138(10):2152-2156. doi: 10.1016/j.jid.2018.04.001. Epub 2018 Apr 13.